These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3271572)

  • 1. [Immunosuppressive factors produced by a T cell line derived from acute lymphoblastic leukemia].
    Cirillo C; Montaldo P; Lanciotti M; Parodi MT; Castagnola E; Ponzoni M
    Boll Ist Sieroter Milan; 1988; 67(4):295-308. PubMed ID: 3271572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human acute leukemia-derived T-cell line produces two inhibitor factors which suppress lymphocyte proliferation: characterization and purification of the molecules.
    Montaldo PG; Lanciotti M; Castagnola E; Parodi MT; Cirillo C; Cornaglia-Ferraris P; Ponzoni M
    Lymphokine Res; 1988; 7(4):413-27. PubMed ID: 3210814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification to homogeneity and biochemical characterization of two suppressor factors from human malignant T-cells.
    Ponzoni M; Montaldo PG; Lanciotti M; Castagnola E; Cirillo C; Cornaglia-Ferraris P
    Biochem Biophys Res Commun; 1988 Jan; 150(2):702-10. PubMed ID: 3257694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a monoclonal nonspecific suppressor factor (MNSF) produced by a T cell hybridoma.
    Nakamura M; Ogawa H; Tsunematsu T
    J Immunol; 1986 Apr; 136(8):2904-9. PubMed ID: 2420877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
    Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
    J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral factors in very young NZB mice that enhance the maturation of normal B cell precursors. Partial purification and characterization.
    Jyonouchi H; Kimmel MD; Lee G; Kincade PW; Good RA
    J Immunol; 1985 Sep; 135(3):1891-9. PubMed ID: 3926891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a human nonspecific suppressor factor from ascitic fluid of systemic lupus erythematosus. Evidence for a human counterpart of the monoclonal nonspecific suppressor factor and relationship to the T cell receptor alpha-chain.
    Xavier RM; Nakamura M; Tsunematsu T
    J Immunol; 1994 Mar; 152(5):2624-32. PubMed ID: 8133068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and analysis of isoforms of soluble immune response suppressor (SIRS).
    Webb DR; Mason K; Semenuk G; Aune TM; Pierce CW
    J Immunol; 1985 Nov; 135(5):3238-42. PubMed ID: 4045193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
    Schwyzer M; Fontana A
    J Immunol; 1985 Feb; 134(2):1003-9. PubMed ID: 3871205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
    Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
    Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells.
    Bruserud O; Ulvestad E
    Cancer Immunol Immunother; 2003 Apr; 52(4):215-25. PubMed ID: 12669246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor cell-inducing factor: a new lymphokine secreted by a natural suppressor cell line with natural cytotoxic activity. I. Purification to apparent homogeneity and initial characterization of suppressor cell-inducing factor.
    Almawi WY; Dolphin PJ; Thies RL; McMaster WR; Levy JG; Pope BL
    J Immunol; 1988 Oct; 141(8):2529-35. PubMed ID: 3171178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of SRIK-NKL: a novel CD8+ natural killer/T cell line derived from a patient with leukemic phase of acute lymphoblastic lymphoma.
    Srivastava BI; Srivastava MD
    Leuk Res; 2005 Jul; 29(7):771-83. PubMed ID: 15927673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
    Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
    Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and partial characterization of a monoclonal "second order" suppressor factor specific for L-glutamic acid60-L-alanine30-L-tyrosine10.
    Turck CW; Kapp JA; Webb DR
    J Immunol; 1985 Nov; 135(5):3232-7. PubMed ID: 2413116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and purification of mouse macrophage procoagulant-inducing factor.
    Ryan J; Geczy CL
    J Immunol; 1986 Nov; 137(9):2864-70. PubMed ID: 3760575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an eosinophilic leukemia cell differentiation factor (ELDF) produced by a human T cell leukemia cell line, HIL-3.
    Ohshima Y; Morita M; Hirashima M; Mori KJ; Akutagawa H; Katamura K; Mayumi M; Mikawa H
    Exp Hematol; 1993 Jun; 21(6):749-54. PubMed ID: 8500576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.